Covington Webinar Series: Part 2| The Global Competitive Landscape – “Most-Favored-Nation” Drug Pricing in the U.S.

Please join us for part 2 of a virtual briefing by Covington's leading life sciences team providing an update on the latest developments in the Trump administration’s Most-Favored-Nation (MFN) Drug Pricing Initiative.

Presenters

Grant Castle, Partner
gcastle@cov.com

Victoria Corke, Of Counsel
vcorke@cov.com

TJ Garrigan, Senior Advisor
tgarrigan@cov.com

Kristie Gurley, Partner
kgurley@cov.com

Cecilia Malmström, Senior Advisor
malmstromc@cov.com

Lauren Rakitin, Partner
lrakitin@cov.com

Arun Venkataraman, Partner
avenkataraman@cov.com

Sibel Yilmaz, Partner
syilmaz@cov.com

Event Details:

Thursday, February 12, 2026
11 a.m. – 1 p.m. EST
4 p.m. – 6 p.m. GMT
5 p.m. – 7 p.m. CET

Log-in details will be provided upon registration.

This invite only webinar is closed to media.

Alert Links:

Please click below to view our latest MFN related alerts.

• Trump Administration Announces New CMMI Models: GLOBE, GUARD, and BALANCE
• Trump Administration Announces Medicaid Model for Most Favored Nation Pricing

CLE: This program is pending accreditation for CLE in CA and NY (for both newly admitted and experienced attorneys). Credit will be applied as requested but cannot be guaranteed for VA or WA. The following jurisdictions may accept reciprocal credit: AZ, AR, CT, NJ, and HI. A general certificate of attendance and necessary materials will be provided for all other jurisdictions to support self-application.